| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086849 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/04/2002 | US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
| 07/04/2002 | US20020086844 Methods and reagents to regulate apoptosis |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086823 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086822 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086821 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer |
| 07/04/2002 | US20020086817 Mannan-binding protein or gene; vaccinia virus vectors |
| 07/04/2002 | US20020086813 Mutants of streptococcal toxin a and methods of use |
| 07/04/2002 | US20020086811 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease |
| 07/04/2002 | US20020086426 Controlling gene expression; obtain cell, transform with expression vector, transcribe and monitor generation of tetracycline |
| 07/04/2002 | US20020086425 Prepartion of growth nutrient for plants; obtain plant, remove stems, propagate in tissue culture |
| 07/04/2002 | US20020086423 Hydrogel thin film containing extracellular matrix components |
| 07/04/2002 | US20020086422 Preferential stem cells, for use in the treatment of autoimmune and immunological defects |
| 07/04/2002 | US20020086421 Tumor cells with increased immunogenicity and uses therefor |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086412 Generating preferential bacteria; obtain genetically engineered bacteria sample, inoculate nutrient broth, propagate, express genes, recover heterologous products |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086394 Enzymatic polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and nervous system disorders |
| 07/04/2002 | US20020086383 Cell expansion factor; for use in the treatment and prevention of graft rejection |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086380 Enzymatic polypeptide for use in animal feeds and in generating chemical intermediates for vitamin A |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086369 Expression vectors for use as tools in human therapeutics and diagnostics |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086353 Nucleotide sequences coding polypeptides for use in the treatment of cancer, skin, immunological, nervous system, develpomental and cardiovascular disorders |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086330 Nucleotide sequences coding polypeptide for use in diagnosis, prevention and treatment of preferential urogenital disorders |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086063 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020086005 Tolerizing allografts of pluripotent stem cells |
| 07/04/2002 | US20020085998 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085996 Can be administered before, at the same time as, or after the transplant. |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | US20020085993 Antigens of the invention may be used as immunogens for vaccines or for the treatment of autoimmune diseases such as juvenile diabetes and multiple sclerosis. |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2436501A1 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | CA2433171A1 Human fgf23 protein mutants decreasing blood phosphorus level |
| 07/04/2002 | CA2432977A1 New use of artemin, a member of the gdnf ligand family |
| 07/04/2002 | CA2432943A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 07/04/2002 | CA2432683A1 Screening method based on siah-numb interaction |
| 07/04/2002 | CA2432574A1 Culturing tissue using magnetically generated mechanical stresses |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2432415A1 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | CA2432380A1 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | CA2432079A1 Process for producing coenzyme q10 |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218529A1 Reverse transfection method |
| 07/03/2002 | EP1218528A1 Producer cell for the production of retroviral vectors |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218520A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218519A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218492A1 Method and system for non-random selection of plant and tissue products |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218490A2 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs |
| 07/03/2002 | EP1218489A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 07/03/2002 | EP1218487A2 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 07/03/2002 | EP1218413A2 Engineering antibodies that bind irreversibly |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218396A1 Antibodies specific for fullerenes |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218028A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 07/03/2002 | EP1217963A1 Devices and methods for treating tissue |
| 07/03/2002 | EP1012174A4 Nik proteins, nucleic acids and methods |